Fixed-dose combination
Anhydrous citric acid, Dextrose and Trisodium is a fixed-dose combination of an anti-coagulant and a calculi dissolution agent. It is available as injection and solution for extracorporeal and intravenous use. MedsAcross supplies Anhydrous citric acid, Dextrose and Trisodium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.
Source: US FDA prescribing information
Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.
Source: US FDA prescribing information
NOT FOR DIRECT INTRAVENOUS INFUSION
Source: US FDA prescribing information
NOT FOR DIRECT INTRAVENOUS INFUSION
Source: US FDA prescribing information
Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).
Source: US FDA prescribing information
It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F), however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Anhydrous citric acid, Dextrose and Trisodium, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Anticoagulant Citrate Dextrose A 0.073 g/0.245 g/0.22 g per 10 mL solutionExtracorporeal | Anhydrous citric acid, Dextrose and Trisodium | Citra Labs | US FDA | Available on request |
| ACD Blood-Pack Units (PL 146 PLASTIC) 493 mg/1.65 g/1.48 g per 67.5 mL injectionIntravenous | Anhydrous citric acid, Dextrose and Trisodium | Fenwal | US FDA | Available on request |
2 brand names across 1 markets.
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 2 presentations of Anhydrous citric acid, Dextrose and Trisodium and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 2 brand names for Anhydrous citric acid, Dextrose and Trisodium, including ACD Blood-Pack Units (PL 146 PLASTIC), Anticoagulant Citrate Dextrose A.
No listed presentation of Anhydrous citric acid, Dextrose and Trisodium is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.